GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (NSE:INDOCO) » Definitions » EBITDA Margin %

Indoco Remedies (NSE:INDOCO) EBITDA Margin % : 9.71% (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Indoco Remedies's EBITDA for the three months ended in Sep. 2024 was ₹418 Mil. Indoco Remedies's Revenue for the three months ended in Sep. 2024 was ₹4,307 Mil. Therefore, Indoco Remedies's EBITDA margin for the quarter that ended in Sep. 2024 was 9.71%.


Indoco Remedies EBITDA Margin % Historical Data

The historical data trend for Indoco Remedies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indoco Remedies EBITDA Margin % Chart

Indoco Remedies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.27 18.56 21.96 17.51 14.80

Indoco Remedies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.01 12.44 16.01 11.50 9.71

Competitive Comparison of Indoco Remedies's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Indoco Remedies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indoco Remedies's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indoco Remedies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Indoco Remedies's EBITDA Margin % falls into.



Indoco Remedies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Indoco Remedies's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=2647.43/17882.155
=14.80 %

Indoco Remedies's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=418.1/4306.6
=9.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indoco Remedies  (NSE:INDOCO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Indoco Remedies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Indoco Remedies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Indoco Remedies Business Description

Traded in Other Exchanges
Address
166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.

Indoco Remedies Headlines

No Headlines